Consumers Intl. says 20 top drug companies' marketing practices mislead the public on drug safety

Get RSS feed of these results

All components of this story

Article
11 August 2006

Report reveals tricks of pharmaceutical trade

Author: Sarah Boseley, Guardian [UK]

The Consumers International report says drug companies use unscrupulous and unethical marketing tactics not only to influence doctors to prescribe their products but also subtly to persuade consumers that they need them...the companies violate their own industry's ethical marketing codes. Patients' health may suffer if a drug such as Vioxx - a painkiller later withdrawn - is over-promoted. Yet, says Consumers International in its report, there is "a shocking lack of publicly available information about the $60bn spent annually by the industry on drug promotion". The report...[says]...Drug companies...make inaccurate claims about the safety and efficacy of their drugs..."This type of 'nice-and-friendly' marketing is often disguised as corporate social responsibility..." says Consumers International. [also refers to Pfizer, Eli Lilly, Novartis, Wyeth]

Read the full post here

Article
1 June 2006

[PDF] Branding the Cure: A consumer perspective on Corporate Social Responsibility, Drug Promotion and the Pharmaceutical Industry

Author: Consumers International

Main findings: Limited transparency in reporting CSR information...New marketing tactics may not be to consumers’ benefit...Breaches of regulations and CSR codes occur with regular frequency showing weak industry self-regulation...Strong and effective CSR must support [the following rights:] the right to safety [,] the right to be informed [,] the right to satisfaction of basic needs [,] the right to education [,] the right to a healthy environment. [The companies studied included: Abbott, AstraZeneca, Almirall Prodesfarma, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson (J&J), Lilly (Eli), Lundbeck, Menarini, Merck Sharp Dohme, Novartis, Novo Nordisk [part of Novo Group], Nycomed, Orion Pharma, Pfizer, Roche, Sanofi-Aventi, Schering AG, Schering-Plough, Wyeth]

Read the full post here

Article
+ Español - Hide

Author: Consumers International

Resultados principales: Transparencia limitada a la hora de informar sobre RSE...Las nuevas tácticas de publicidad pueden no beneficiar a los consumidores...Las violaciones de los reglamentos y códigos de RSE ocurren con frecuencia periódica, lo cual demuestra una pobre autorregulación en este sector de la industria...Las Directrices de la ONU sobre la Protección del Consumidor...contienen...derechos básicos: derecho a la seguridad [,] derecho a la información [,] derecho a satisfacer necesidades básicas [,] derecho a la educación [,] derecho a un medioambiente sano. [Entre las empresas evaluadas se encuentran las siguientes: Abbott, AstraZeneca, Almirall Prodesfarma, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson (J&J), Lilly (Eli), Lundbeck, Menarini, Merck Sharp Dohme, Novartis, Novo Nordisk, Nycomed, Orion Pharma, Pfizer, Roche, Sanofi-Aventi, Schering AG, Schering-Plough, Wyeth]

🚫Read the full post here

Article
+ Français - Hide

Author: Consumers International

Les principaux résultats: Transparence limitée en matière de signalement des informations relatives à la RSE...Il se peut que les nouvelles tactiques marketing ne soient pas dans l’intérêt des consommateurs...Des violations des règlements et codes RSE surviennent régulièrement, montrant la faiblesse du secteur en matière d’autoréglementation...Les principes directeurs des Nations unies pour la protection des consommateurs...couvrent huit droits essentiels, à savoir: Le droit à la sécurité [,] Le droit à l’information [,] Le droit à la satisfaction des besoins de base [,] Le droit à l’éducation [,] Le droit à un environnement sain. [Les sociétés ayant fait l’objet de l’étude sont les suivantes: Abbott, AstraZeneca, Almirall Prodesfarma, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson (J&J), Lilly (Eli), Lundbeck, Menarini, Merck Sharp Dohme, Novartis, Novo Nordisk, Nycomed, Orion Pharma, Pfizer, Roche, Sanofi-Aventis, Schering AG, Schering-Plough, Wyeth]

🚫Read the full post here